Navigation Links
WBAL Radio Segment With Dr. Leigh Vinocur Addresses Hope for the Rosacea Sufferer
Date:3/13/2009

- Dr. Vinocur Reports on University of California Rosacea-Specific Study -

NAPA, Calif., March 13 /PRNewswire-FirstCall/ -- On March 9, 2009, Dr. Leigh Vinocur, medical expert from the University of Maryland School of Medicine, was featured on WBAL-AM 1090 in a segment on rosacea, a condition afflicting over 14 million Americans. Dr. Vinocur addressed current therapies while reporting on a new study conducted at the Department of Dermatology, University of California, Irvine, in which rosacea patients were treated with a new cosmeceutical, Pyratine XR(TM) (0.125% furfuryl tetrahydropyranyl adenine).

Rosacea is a chronic skin disorder characterized by dilated blood vessels on the face, redness, inflammation, and lesions (papules and pustules). According to Dr. Vinocur, traditional treatments for rosacea focus on topical and oral antibiotics for their anti-inflammatory properties, but the new study showed that cytokinins, natural plant-derived growth factors known for their antioxidant and moisture retention benefits, appear to significantly reduce rosacea symptoms.

Over the 48-week study with Pyratine XR(TM) there was an overall clinical improvement in 80% of subjects with a 90% improvement in lesions, 45% improvement in redness, and a 28% improvement in spider veins. The product also appeared to improve the skin barrier function with a 41% improvement in skin dryness as early as week four while appearing to concurrently reduce fine lines, wrinkles and hyperpigmentation.

Pyratine XR(TM) is manufactured by Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging. Pyratine XR(TM) officially launched at the American Academy of Dermatology's 67th Annual Meeting in San Francisco, March 6-10, 2009.

For more information on Pyratine XR(TM), please visit www.PyratineXR.com.

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
2. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
3. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
4. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
5. Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
6. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
7. Society of Interventional Radiology Applauds Reports Uterine Fibroid Embolization Recommendations
8. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
9. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
10. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
11. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Jan. 16, 2017 Summary ... to 2022", provides key market data on the North ... millions of US dollars, volume (in units) and average ... Absorptiometry (DEXA) and Quantitative Ultrasound (QUS). The report ... each of these market segements, and global corporate-level profiles ...
(Date:1/16/2017)...  Verathon ® Inc., a leading manufacturer and marketer of ... ® Spectrum TM Single-Use video laryngoscopes. The ... Ambient Light Reduction TM technology, which actively optimizes image quality. ... ... Introducing another bright idea from GlideScope(R) ...
(Date:1/16/2017)... -- When synthetic Fentanyl arrived on the streets in 2015, ... offered free samples, inviting would-be customers to test a newly-created ... The rapidly-growing demand for ... than morphine, has racked up a staggering death toll across ... dealer,s recorded fentanyl sales reveals that they have sold nearly ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... 2017 , ... To provide comfort and fuel during the ... category, announces a hearty and wholesome Winter Menu. Starting today, guests can enjoy ... Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage Soup, and ...
(Date:1/16/2017)... New York, NY (PRWEB) , ... January 16, 2017 , ... ... the grand opening of a new showroom in East Hanover, New Jersey. , “We ... at Gym Source. “The new innovative in-store concept is designed to give clients a ...
(Date:1/16/2017)... ... ... Anybody who may be looking for a substance abuse rehabilitation program with a ... holistic treatment center for addiction located in Marne, MI. This video, which can be ... staff that visited the 2016 Recovery Palooza support event in nearby Grand Rapids. , ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Prairie’s award-winning Reflection® brand of custom seating systems has a well-earned reputation for ... with a platform for innovation and growth in the custom seating business, which ...
(Date:1/16/2017)... ... , ... St. Louisans are well-aware of the following facts at present:, ... to be having no effect on keeping this particularly bad strain of the flu away ... coughing, sneezing, or sniffling , These facts are well-known among the team ...
Breaking Medicine News(10 mins):